Skip to main content

Advertisement

SpringerLink
Log in

Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Aricò M, Biondi A, Pui CH . Juvenile myelomonocytic leukemia. Blood 1997; 90: 479–488.

    PubMed  Google Scholar 

  2. Niemeyer CM, Kratz CP . Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 2008; 140: 210–224.

    Article  Google Scholar 

  3. Emanuel PD . Juvenile myelomonocytic leukaemia and chronic myelomonocytic leukemia. Leukemia 2008; 22: 1335–1342.

    Article  CAS  PubMed  Google Scholar 

  4. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS . Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77: 925–929.

    CAS  PubMed  Google Scholar 

  5. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148–150.

    Article  CAS  PubMed  Google Scholar 

  6. Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999; 13: 32–37.

    Article  CAS  PubMed  Google Scholar 

  7. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998; 92: 267–272.

    CAS  PubMed  Google Scholar 

  8. Van Meter ME, Díaz-Flores E, Archard JA, Passegué E, Irish JM, Kotecha N et al. K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood 2007; 109: 3945–3952.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118: 217–228.

    Article  CAS  PubMed  Google Scholar 

  10. Kotecha N, Flores NJ, Irish JM, Sakaguchi D, Archambeault S, Diaz-Flores E et al. A novel assay for juvenile myelomonocytic leukemia based on aberrant signaling networks measured via phospho-specific flow cytometry reduces diagnosis time from weeks to days. Blood 2007; 110: 546a.

    Google Scholar 

  11. Locatelli F, Nöllke P, Zecca M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410–419.

    Article  CAS  PubMed  Google Scholar 

  12. Archambeault S, Flores NJ, Yoshimi A, Kratz CP, Reising M, Fischer A et al. Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood 2008; 111: 1124–1127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lorenzana A, Lyons H, Sawaf H, Higgins M, Carrigan D, Emanuel PD . Human Herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediat Hematol Oncol 2002; 24: 136–141.

    Article  Google Scholar 

  14. Teofili L, Martini M, Cenci T, Petrucci G, Torti L, Storti S et al. Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood 2007; 110: 354–359.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was initiated and promoted by the Fondazione Tettamanti and Associazione Italiana per la Ricerca sul Cancro, MIUR PRIN 2005.

Author information

Authors and Affiliations

  1. Centro Ricerca M. Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza (MI), Italy

    G Gaipa, C Bugarin, D Longoni, S Cesana, C Molteni & A Biondi

  2. Dipartimento di Medicina Clinica e Prevenzione, Facolta' di Medicina e Chirurgia, Università di Milano-Bicocca, Monza (MI), Italy

    A Faini

  3. Department of Pediatric Hematology-Oncology, University of Torino, Torino, Italy

    F Timeus

  4. Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

    M Zecca

Authors
  1. G Gaipa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Bugarin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Longoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Cesana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Molteni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Faini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Timeus
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Zecca
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Gaipa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaipa, G., Bugarin, C., Longoni, D. et al. Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement. Leukemia 23, 791–793 (2009). https://doi.org/10.1038/leu.2008.265

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.265

  • Springer Nature Limited

This article is cited by

Search

Navigation